Ignite Creation Date:
2024-05-06 @ 2:08 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04225429
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-03-22
First Post:
2020-01-08
Brief Title:
Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma
Sponsor:
Epizyme Inc
Organization:
Ipsen